Cargando…

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program

PURPOSE: Efficient management of COPD represents an international challenge. Effective management strategies within the means of limited health care budgets are urgently required. This analysis aimed to evaluate the cost-effectiveness of a home-based disease management (DM) intervention vs usual man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourbeau, Jean, Granados, Denis, Roze, Stéphane, Durand-Zaleski, Isabelle, Casan, Pere, Köhler, Dieter, Tognella, Silvia, Viejo, Jose Luis, Dal Negro, Roberto W, Kessler, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421871/ https://www.ncbi.nlm.nih.gov/pubmed/30936689 http://dx.doi.org/10.2147/COPD.S173057

Ejemplares similares

An international randomized study of a home-based self-management program for severe COPD: the COMET
por: Bourbeau, Jean, et al.
Publicado: (2016)

Optimizing economic outcomes in the management of COPD
por: Dal Negro, Roberto
Publicado: (2008)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
por: Dal Negro, Roberto W, et al.
Publicado: (2012)

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

eHealth in Self-Managing at a Distance Patients with COPD
por: Kermelly, Sophie B., et al.
Publicado: (2022)

Multicentre comparison of self-management in patients with COPD
por: Wakabayashi, Ritsuko, et al.
Publicado: (2021)

Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity
por: Dal Negro, Roberto W, et al.
Publicado: (2013)

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit
por: Saleh, Aarash, et al.
Publicado: (2015)

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values
por: Dal Negro, Roberto W, et al.
Publicado: (2014)

The Quebec Respiratory Health Education Network: Integrating a model of self-management education in COPD primary care
por: Bourbeau, Jean, et al.
Publicado: (2017)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
por: Recio Iglesias, Jesús, et al.
Publicado: (2020)

Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
por: Delmas, Clément, et al.
Publicado: (2022)

COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power
por: Dal Negro, Roberto W.
Publicado: (2019)

The complexity of managing COPD exacerbations: a grounded theory study of European general practice
por: Risør, Mette Bech, et al.
Publicado: (2013)

Prevalence of different comorbidities in COPD patients by gender and GOLD stage
por: Dal Negro, R. W., et al.
Publicado: (2015)

Managing comorbidities in COPD
por: Hillas, Georgios, et al.
Publicado: (2015)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Managing COPD exacerbation at home- Teleconsultations amid COVID-19
por: Shahnawaz, Mir, et al.
Publicado: (2022)

European Hernia Society guidelines on management of rectus diastasis
por: Hernández-Granados, P, et al.
Publicado: (2021)

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT
por: Trappenburg, Jaap CA, et al.
Publicado: (2009)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Key Highlights of the Canadian Thoracic Society’s Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic
por: Bhutani, Mohit, et al.
Publicado: (2020)

Dyspnea in COPD: New Mechanistic Insights and Management Implications
por: O’Donnell, Denis E., et al.
Publicado: (2019)

Using the pulmonary function laboratory to assist in disease management: COPD
por: Neder, José Alberto, et al.
Publicado: (2023)

Role of arformoterol in the management of COPD
por: King, Paul
Publicado: (2008)

Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006)

The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007)

Hyperinflation and its management in COPD
por: Puente-Maestu, Luis, et al.
Publicado: (2006)

Tailoring of corticosteroids in COPD management
por: De Coster, Daan A., et al.
Publicado: (2014)

COPD heterogeneity: implications for management
por: Barrecheguren, Miriam, et al.
Publicado: (2016)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Early COPD Diagnosis in Family Medicine Practice: How to Implement Spirometry?
por: Saad, Nathalie, et al.
Publicado: (2014)

La neumología pos-COVID-19
por: Casan Clarà, Pere, et al.
Publicado: (2020)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_afjhjbf0hjds4g2s1a66dp5b70